Aushon Biosystems

Near-term the deal gives Quanterix a CLIA lab while securing technologies that could improve assay multiplexing and support its longer term clinical goals.

The company has developed a series of cytokine immunoassays for its Ciraplex platform that it said can achieve sensitivity in the femtogram per ml range.

NEW YORK (GenomeWeb) – Aushon Biosystems has been building up its IP portfolio ahead of a planned expansion to its Cira immunoassay platform.

Title: Method of and system for applying blocking material to assay substrates.
Patent Number: 8,685,486
Filed: Aug. 10, 2011

Richard Smith, director of proteomics at Pacific Northwest National Laboratory, has been named recipient of the 2013 Award for a Distinguished Contribution in Mass Spectrometry by the American Society for Mass Spectrometry.

People In The News

NEW YORK (GenomeWeb News) – Ariosa Diagnostics has appointed Michael Aicher to its board of directors. He is currently the CEO of Omicia. Previously, he was co-founder and CEO of the National Genetics Institute, a wholly owned subsidiary of Laboratory Corporation of America.

Agilent Technologies said this week that it has awarded its Agilent Thought Leader Award to Ronald DePinho, an oncologist at the University of Texas MD Anderson Cancer Center.

NEW YORK (GenomeWeb News) – Aushon BioSystems said today that it has appointed AH Diagnostics to be its exclusive distributor in Scandinavia, effective immediately.

BG Medicine has appointed Charles Abdalian to be executive VP and chief financial officer. Mike Rogers will be departing the company after three-and-a-half years as CFO.

Aushon BioSystems has appointed Martin Verhoef to be company CEO and to serve on its board of directors.

Pages

A genome-wide association study highlights a potential role for hair follicles in acne risk, according to New Scientist.

Newsday reports that breast cancer genetic testing guidelines for are out of date and may miss individuals.

In Cell this week: gene editing-based strategy to screen for immune system regulators, ancient plague patterns, and more.

Publication of He Jiankui's work on gene-edited infants would raise ethical concerns for journals, Wired and others report.